The NPSC male contraceptive programme featured in MIT Technology Review

on .

NPSC's phenotypic screening platform is at the heart of efforts to develop a male pill.

The Bill and Melinda Gates Foundation have pledged $600,000 towards finding novel approaches to male birth control, which has been awarded to several laboratories worldwide. Different approches are being used to address the challenge, including genetic approaches to identify genes that might be good contraceptive targets, induced pluripotent stem cell approaches to find a better human model for male-contraceptive drug screening, and phenotypic approaches to identify agents that act on sperm function and fertility. NPSC is contributing to this this effort with high throughput biology and novel multiparametric phenotypic screening methods. High content imaging technology will be used to track sperm movement and to capture the “acrosome reaction,” when sperm shed a cap-like structure before penetrating an egg. A drug able to immobilize sperm, or block that reaction, could be a starting point for an effective contraceptive.

Link to full article in MIT Technology Review

2017 03 03 MITreview



NPSC is a facility run and operated by the Universities of Dundee, Edinburgh and Oxford, which are registered UK-based charities. 

Copyright © 2016.